Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2005 Oct;81(960):667–672. doi: 10.1136/pgmj.2004.030817

Change of nitric oxide in experimental colitis and its inhibition by melatonin in vivo and in vitro

Q Mei 1, J Xu 1, L Xiang 1, Y Hu 1, X Hu 1, Z Xu 1
PMCID: PMC1743367  PMID: 16210467

Abstract

Aim: To investigate the change of nitric oxide (NO) in rat colitis and its inhibition by melatonin in vivo and in vitro.

Methods: In vivo, rat colitis was established intracolonically with trinitrobenzenesulphonic acid (TNBS) and ethanol. The animals were randomised into five groups: control group, model group, melatonin group (2.5, 5.0, 10.0 mg/kg), and treated intracolonically with saline, saline and melatonin respectively (once a day, from day 7 after colitis was established to day 28). After the end of the experiment, the mucosal damage index (CMDI) and histology score (HS) were evaluated and the level of myeloperoxidase (MPO) and malondiadehyde (MDA) and NO in the colon tissue were measured. In vitro, the co-culture model of the inflamed colon mucosa (from the colitis) with lipopolysaccharide (LPS), and the colonocytes oxidative injury model by hydroxyl radical, were designed respectively to elucidate the inhibition of NO by melatonin.

Results: After treated with TNBS/ethanol, the extent of CMDI and HS, the levels of MPO, MDA, and NO in the model group, were higher than that in the control group; melatonin ameliorated these parameters effectively. The stimulation of LPS increased the level of NO and MPO and MDA in the co-culture model of inflamed colon mucosa, and melatonin significantly reduced the level of MPO, MDA, and NO. In the coloncyte oxidative injury model by hydroxyl radical, the contents of LDH, MDA, and NO were increased; melatonin reversed this oxidative injury considerably.

Conclusion: This study showed that TNBS/ethanol induced colitis was pharmacologically controlled by melatonin in vivo and in vitro.

Full Text

The Full Text of this article is available as a PDF (83.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baten A., Sakamoto K., Shamsuddin A. M. Long-term culture of normal human colonic epithelial cells in vitro. FASEB J. 1992 Jun;6(9):2726–2734. doi: 10.1096/fasebj.6.9.1377141. [DOI] [PubMed] [Google Scholar]
  2. Bubenik G. A. Localization, physiological significance and possible clinical implication of gastrointestinal melatonin. Biol Signals Recept. 2001 Nov-Dec;10(6):350–366. doi: 10.1159/000046903. [DOI] [PubMed] [Google Scholar]
  3. Bycroft J., Shergill I. S., Chung E. A. L., Choong E. A. L., Arya N., Shah P. J. R. Autonomic dysreflexia: a medical emergency. Postgrad Med J. 2005 Apr;81(954):232–235. doi: 10.1136/pgmj.2004.024463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cuzzocrea S., Costantino G., Caputi A. P. Protective effect of melatonin on cellular energy depletion mediated by peroxynitrite and poly (ADP-ribose) synthetase activation in a non-septic shock model induced by zymosan in the rat. J Pineal Res. 1998 Sep;25(2):78–85. doi: 10.1111/j.1600-079x.1998.tb00543.x. [DOI] [PubMed] [Google Scholar]
  5. Cuzzocrea S., Mazzon E., Serraino I., Lepore V., Terranova M. L., Ciccolo A., Caputi A. P. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res. 2001 Jan;30(1):1–12. doi: 10.1034/j.1600-079x.2001.300101.x. [DOI] [PubMed] [Google Scholar]
  6. Daniels W. M., Reiter R. J., Melchiorri D., Sewerynek E., Pablos M. I., Ortiz G. G. Melatonin counteracts lipid peroxidation induced by carbon tetrachloride but does not restore glucose-6 phosphatase activity. J Pineal Res. 1995 Aug;19(1):1–6. doi: 10.1111/j.1600-079x.1995.tb00164.x. [DOI] [PubMed] [Google Scholar]
  7. Dieleman L. A., Palmen M. J., Akol H., Bloemena E., Peña A. S., Meuwissen S. G., Van Rees E. P. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol. 1998 Dec;114(3):385–391. doi: 10.1046/j.1365-2249.1998.00728.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dong Wei-Guo, Mei Qiao, Yu Jie-Ping, Xu Jian-Ming, Xiang Li, Xu Yu. Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis. World J Gastroenterol. 2003 Jun;9(6):1307–1311. doi: 10.3748/wjg.v9.i6.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Elson C. O., Sartor R. B., Tennyson G. S., Riddell R. H. Experimental models of inflammatory bowel disease. Gastroenterology. 1995 Oct;109(4):1344–1367. doi: 10.1016/0016-5085(95)90599-5. [DOI] [PubMed] [Google Scholar]
  10. Gilad E., Cuzzocrea S., Zingarelli B., Salzman A. L., Szabó C. Melatonin is a scavenger of peroxynitrite. Life Sci. 1997;60(10):PL169–PL174. doi: 10.1016/s0024-3205(97)00008-8. [DOI] [PubMed] [Google Scholar]
  11. Grisham M. B., Johnson G. G., Lancaster J. R., Jr Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol. 1996;268:237–246. doi: 10.1016/s0076-6879(96)68026-4. [DOI] [PubMed] [Google Scholar]
  12. Grisham M. B., Jourd'Heuil D., Wink D. A. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites:implications in inflammation. Am J Physiol. 1999 Feb;276(2 Pt 1):G315–G321. doi: 10.1152/ajpgi.1999.276.2.G315. [DOI] [PubMed] [Google Scholar]
  13. Grisham M. B., Specian R. D., Zimmerman T. E. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J Pharmacol Exp Ther. 1994 Nov;271(2):1114–1121. [PubMed] [Google Scholar]
  14. Hata Y., Kawabe T., Hiraishi H., Ota S., Terano A., Ivey K. J. Antioxidant defenses of cultured colonic epithelial cells against reactive oxygen metabolites. Eur J Pharmacol. 1997 Feb 19;321(1):113–119. doi: 10.1016/s0014-2999(96)00929-6. [DOI] [PubMed] [Google Scholar]
  15. Hata Y., Kawabe T., Hiraishi H., Ota S., Terano A., Ivey K. J. Hydrogen peroxide-mediated cytotoxicity to cultured colonic epithelial cells. Life Sci. 1997;60(24):2221–2230. doi: 10.1016/s0024-3205(97)00237-3. [DOI] [PubMed] [Google Scholar]
  16. Kimura H., Miura S., Shigematsu T., Ohkubo N., Tsuzuki Y., Kurose I., Higuchi H., Akiba Y., Hokari R., Hirokawa M. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci. 1997 May;42(5):1047–1054. doi: 10.1023/a:1018849405922. [DOI] [PubMed] [Google Scholar]
  17. Kolios G., Rooney N., Murphy C. T., Robertson D. A., Westwick J. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut. 1998 Jul;43(1):56–63. doi: 10.1136/gut.43.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lundberg J. O., Hellström P. M., Lundberg J. M., Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet. 1994 Dec 17;344(8938):1673–1674. doi: 10.1016/s0140-6736(94)90460-x. [DOI] [PubMed] [Google Scholar]
  19. Lähde M., Korhonen R., Moilanen E. Regulation of nitric oxide production in cultured human T84 intestinal epithelial cells by nuclear factor-kappa B-dependent induction of inducible nitric oxide synthase after exposure to bacterial endotoxin. Aliment Pharmacol Ther. 2000 Jul;14(7):945–954. doi: 10.1046/j.1365-2036.2000.00781.x. [DOI] [PubMed] [Google Scholar]
  20. Marshall K. A., Reiter R. J., Poeggeler B., Aruoma O. I., Halliwell B. Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med. 1996;21(3):307–315. doi: 10.1016/0891-5849(96)00046-9. [DOI] [PubMed] [Google Scholar]
  21. Masola B., Evered D. F. Preparation of rat enterocyte mitochondria. Biochem J. 1984 Mar 1;218(2):441–447. doi: 10.1042/bj2180441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. McCafferty D. M. Peroxynitrite and inflammatory bowel disease. Gut. 2000 Mar;46(3):436–439. doi: 10.1136/gut.46.3.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mei Qiao, Yu Jie-Ping, Xu Jian-Ming, Wei Wei, Xiang Li, Yue Li. Melatonin reduces colon immunological injury in rats by regulating activity of macrophages. Acta Pharmacol Sin. 2002 Oct;23(10):882–886. [PubMed] [Google Scholar]
  24. Melchiorri D., Reiter R. J., Attia A. M., Hara M., Burgos A., Nistico G. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci. 1995;56(2):83–89. doi: 10.1016/0024-3205(94)00417-q. [DOI] [PubMed] [Google Scholar]
  25. Middleton S. J., Shorthouse M., Hunter J. O. Increased nitric oxide synthesis in ulcerative colitis. Lancet. 1993 Feb 20;341(8843):465–466. doi: 10.1016/0140-6736(93)90211-x. [DOI] [PubMed] [Google Scholar]
  26. Miller M. J., Sadowska-Krowicka H., Chotinaruemol S., Kakkis J. L., Clark D. A. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther. 1993 Jan;264(1):11–16. [PubMed] [Google Scholar]
  27. Miller M. J., Thompson J. H., Zhang X. J., Sadowska-Krowicka H., Kakkis J. L., Munshi U. K., Sandoval M., Rossi J. L., Eloby-Childress S., Beckman J. S. Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology. 1995 Nov;109(5):1475–1483. doi: 10.1016/0016-5085(95)90633-9. [DOI] [PubMed] [Google Scholar]
  28. Morris G. P., Beck P. L., Herridge M. S., Depew W. T., Szewczuk M. R., Wallace J. L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989 Mar;96(3):795–803. [PubMed] [Google Scholar]
  29. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992 Sep;6(12):3051–3064. [PubMed] [Google Scholar]
  30. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979 Jun;95(2):351–358. doi: 10.1016/0003-2697(79)90738-3. [DOI] [PubMed] [Google Scholar]
  31. Pentney P. T., Bubenik G. A. Melatonin reduces the severity of dextran-induced colitis in mice. J Pineal Res. 1995 Aug;19(1):31–39. doi: 10.1111/j.1600-079x.1995.tb00168.x. [DOI] [PubMed] [Google Scholar]
  32. Rachmilewitz D., Karmeli F., Okon E., Bursztyn M. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut. 1995 Aug;37(2):247–255. doi: 10.1136/gut.37.2.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rachmilewitz D., Simon P. L., Schwartz L. W., Griswold D. E., Fondacaro J. D., Wasserman M. A. Inflammatory mediators of experimental colitis in rats. Gastroenterology. 1989 Aug;97(2):326–337. doi: 10.1016/0016-5085(89)90068-1. [DOI] [PubMed] [Google Scholar]
  34. Rachmilewitz D., Stamler J. S., Bachwich D., Karmeli F., Ackerman Z., Podolsky D. K. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut. 1995 May;36(5):718–723. doi: 10.1136/gut.36.5.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rachmilewitz D., Stamler J. S., Bachwich D., Karmeli F., Ackerman Z., Podolsky D. K. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut. 1995 May;36(5):718–723. doi: 10.1136/gut.36.5.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Reiter R. J., Melchiorri D., Sewerynek E., Poeggeler B., Barlow-Walden L., Chuang J., Ortiz G. G., Acuña-Castroviejo D. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res. 1995 Jan;18(1):1–11. doi: 10.1111/j.1600-079x.1995.tb00133.x. [DOI] [PubMed] [Google Scholar]
  37. Reiter R. J. The role of the neurohormone melatonin as a buffer against macromolecular oxidative damage. Neurochem Int. 1995 Dec;27(6):453–460. doi: 10.1016/0197-0186(95)80002-3. [DOI] [PubMed] [Google Scholar]
  38. Roediger W. E., Truelove S. C. Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut. 1979 Jun;20(6):484–488. doi: 10.1136/gut.20.6.484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Salzman A. L., Eaves-Pyles T., Linn S. C., Denenberg A. G., Szabó C. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology. 1998 Jan;114(1):93–102. doi: 10.1016/s0016-5085(98)70637-7. [DOI] [PubMed] [Google Scholar]
  40. Sewerynek E., Abe M., Reiter R. J., Barlow-Walden L. R., Chen L., McCabe T. J., Roman L. J., Diaz-Lopez B. Melatonin administration prevents lipopolysaccharide-induced oxidative damage in phenobarbital-treated animals. J Cell Biochem. 1995 Aug;58(4):436–444. doi: 10.1002/jcb.240580406. [DOI] [PubMed] [Google Scholar]
  41. Singer I. I., Kawka D. W., Scott S., Weidner J. R., Mumford R. A., Riehl T. E., Stenson W. F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology. 1996 Oct;111(4):871–885. doi: 10.1016/s0016-5085(96)70055-0. [DOI] [PubMed] [Google Scholar]
  42. Stasica P., Ulanski P., Rosiak J. M. Melatonin as a hydroxyl radical scavenger. J Pineal Res. 1998 Aug;25(1):65–66. doi: 10.1111/j.1600-079x.1998.tb00387.x. [DOI] [PubMed] [Google Scholar]
  43. Tepperman B. L., Brown J. F., Whittle B. J. Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol. 1993 Aug;265(2 Pt 1):G214–G218. doi: 10.1152/ajpgi.1993.265.2.G214. [DOI] [PubMed] [Google Scholar]
  44. Wardle T. D., Hall L., Turnberg L. A. Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease. Gut. 1992 Dec;33(12):1644–1651. doi: 10.1136/gut.33.12.1644. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES